[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100384323":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":16,"locations":21,"responsibleParty":65,"collaborators":68,"id":73,"slug":7,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":78,"eligibilityCriteria":79,"healthyVolunteers":74,"sex":80,"minAge":81,"maxAge":7,"enrollmentInfo":82,"targetDuration":7,"studyType":85,"phases":7,"briefSummary":86,"conditions":87,"keywords":91,"overallStatus":24,"whyStopped":7,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Kantonsspital Aarau","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Transition model","Transition of follow-up care of childhood cancer survivors to adult care",[13],{"name":14,"affiliation":5,"role":15},"Katrin Scheinemann, MD","PRINCIPAL_INVESTIGATOR",[17],{"name":14,"role":18,"phone":19,"phoneExt":7,"email":20},"CONTACT","004162 838 4909","katrin.scheinemann@ksa.ch",[22,41,53],{"facility":23,"status":24,"city":25,"state":7,"zip":7,"country":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Division of Oncology - Hematology, Department of Pediatrics, Kantonsspital Aarau","RECRUITING","Aarau","Switzerland",{"type":28,"coordinates":29},"Point",[30,31],8.04422,47.39254,{"lat":31,"lon":30},[34,35,36,39],{"name":14,"role":18,"phone":7,"phoneExt":7,"email":7},{"name":14,"role":15,"phone":7,"phoneExt":7,"email":7},{"name":37,"role":38,"phone":7,"phoneExt":7,"email":7},"Maria Otth, MD","SUB_INVESTIGATOR",{"name":40,"role":38,"phone":7,"phoneExt":7,"email":7},"Sibylle Denzler, MD",{"facility":42,"status":24,"city":43,"state":7,"zip":7,"country":26,"cosmosGeoPoint":44,"geoPoint":48,"contacts":49},"Division of Oncology\u002F Hematology, University Children's Hospital Basel","Basel",{"type":28,"coordinates":45},[46,47],7.57327,47.55839,{"lat":47,"lon":46},[50,52],{"name":51,"role":18,"phone":7,"phoneExt":7,"email":7},"Tamara Diesch, MD",{"name":51,"role":15,"phone":7,"phoneExt":7,"email":7},{"facility":54,"status":24,"city":55,"state":7,"zip":7,"country":26,"cosmosGeoPoint":56,"geoPoint":60,"contacts":61},"Division of Oncology\u002F Hematology, Department of Pediatrics, Kantonsspital Lucerne","Lucerne",{"type":28,"coordinates":57},[58,59],8.30635,47.05048,{"lat":59,"lon":58},[62,64],{"name":63,"role":18,"phone":7,"phoneExt":7,"email":7},"Bernhard Eisenreich, MD",{"name":63,"role":15,"phone":7,"phoneExt":7,"email":7},{"type":15,"investigatorFullName":66,"investigatorTitle":67,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Katrin Scheinemann","Division Head of Pediatric Oncology-Hematology",[69,71],{"name":70,"class":6},"University Children's Hospital Basel",{"name":72,"class":6},"Luzerner Kantonsspital","100384323",false,"NCT04284189","Aftercare of Childhood Cancer Survivors in Switzerland","Aftercare of Childhood Cancer Survivors in Switzerland - the ACCS Switzerland Project","ACCS","Inclusion Criteria:\n\n* 5-year survivor of childhood cancer\n* Diagnosis according to ICCC3 I-XII; Langerhans cell histiocytosis (LCH), Hemophagocytic lymphohistiocytosis (HLH)\n* Age at diagnosis \\\u003C18 years\n* Age at study ≥16 years\n* At study start in follow-up care at one of the three pediatric oncology centers (group before transition) or transitioned not before 2014 (group after transition).\n* Written informed consent\n\nExclusion Criteria:\n\n* Treatment only by means of surgery and without increased risk of late effects (e.g. teratoma)\n* \\\u003C5 years after therapy of a relapse or palliative situation\n* Severe cognitive impairment, which makes it impossible to complete the questionnaire independently\n* Insufficient knowledge of the German language\n* Informed consent form not signed","ALL","16 Years",{"count":83,"type":84},140,"ESTIMATED","OBSERVATIONAL","The Aftercare of Childhood Cancer Survivors in Switzerland (ACCS) study is a multicenter cohort study designed to investigate transition of follow-up care from pediatric oncology to adult care in a prospective and longitudinal way. The investigators collect data on preferences and expectations for follow-up care and transition to adult care by questionnaires in adolescent and young adult survivors of childhood cancer.",[88,89,90],"Childhood Cancer","Survivorship","Transition",[92,93],"Childhood Cancer Survivor","Transition of follow-up care","2022-08-16",{"date":96,"type":97},"2022-08-17","ACTUAL",{"date":99,"type":97},"2019-02-12",{"date":101,"type":84},"2030-08",{"name":5,"class":6},3]